The healing powers of
oxygen have been well researched and documented for decades. Contrary
to some marketing opinions, there is no overdose and the consumption
of oxygenated water is therefore entirely risk-free. However, it is
recommended to consumed between 0.75 to 1.5 litre daily.
In 1988, the per oral
(applied through drinking) oxygen therapy (POT) was developed by Prof.
Dr A. Pakdaman of Germany as a promising innovation for use in
clinical-scientific medicine. The therapy was based on the enrichment
of potable water with oxygen of 150mg/l.
water was applied in the nutritional, clinical and research medicine
to treat cellular hypoxia. As therapy, the oxygen-enriched water was
prescribed to people suffering from different diseases such as
migraine, heart arrhythmia, ophtalmological problems and cancer. It
was also applied to improve blood pressure and stimulate the immune
On 4th December 1993,
Prof. Dr. Pakdaman was awarded the annual Manfred Koehnlechner Prize
by the German Research Foundation in Munich for the best research in
biological and natural medicine on his clinical-scientific research
regarding Peroral Oxygen Therapy.
On 10th November 2000,
Prof. Dr. Pakdaman was honoured with the Certificate of Innovations
for his clinical and scientific work in the area of oncology and
oxygen research, especially the Peroral Oxygen Therapy.
and toxicology studies from the University of Munich also documented
marked improvements in physical, intellectual and energetic levels
after the drinking of oxygen-enriched water.